STOCK TITAN

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
OPKO Health, Inc. (NASDAQ: OPK) will report its operating and financial results for the three and nine months ended September 30, 2023 on November 6, 2023. The company's senior management will provide a business update and discuss results during a conference call and live webcast. Participants can pre-register for the conference call to receive a unique PIN for immediate access. The call can be accessed via phone or webcast, and replays will be available.
Positive
  • None.
Negative
  • None.

MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2023 after the close of the U.S. financial markets on Monday, November 6, 2023. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on November 6th beginning at 4:30 p.m. Eastern time.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.

A telephone replay will be available until November 13, 2023 by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 8299382. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com

 


FAQ

When will OPKO Health, Inc. report its operating and financial results?

OPKO Health, Inc. will report its operating and financial results for the three and nine months ended September 30, 2023 on November 6, 2023.

What will OPKO's senior management provide during the conference call?

OPKO's senior management will provide a business update and discuss the company's results.

How can participants pre-register for the conference call?

Participants can pre-register for the conference call using the provided link to receive a unique PIN for immediate access.

How can participants access the conference call?

Participants can access the conference call via phone by dialing either 833-630-0584 (U.S.) or 412-317-1815 (International). They can also access it through the webcast on OPKO's Investor Relations page.

Will there be replays available for the conference call?

Yes, there will be replays available. Participants can access a telephone replay by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 8299382. A webcast replay will also be available on OPKO's Investor Relations page.

Opko Health Inc.

NASDAQ:OPK

OPK Rankings

OPK Latest News

OPK Stock Data

1.07B
310.86M
54.45%
28.02%
14.05%
Diagnostics & Research
Pharmaceutical Preparations
Link
United States of America
MIAMI